UC DIS.CERT. 03/25 ESL/ DE000HD453R4 /
24/06/2024 9:01:20 | Diferencia0.000 | Bid9:20:05 | Ask9:20:05 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
171.250EUR | 0.00% | 171.500 Volumen de oferta: 3,000 |
171.520 Tamaño/ Volumen/ Formato de Ask: 3,000 |
ESSILORLUXO. INH. EO... | - - | 28/03/2025 | Call |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página